Chronic renal dysfunction in cirrhosis: A new frontier in hepatology

Ramesh Kumar1, Rajeev Nayan Priyadarshi2, Utpal Anand3

  • 1Department of Gastroenterology, All India Institute of Medical Sciences, Patna 801507, Bihar, India. docrameshkr@gmail.com.

Insights

Chronic kidney disease (CKD) is increasingly diagnosed in liver cirrhosis patients due to risk factors like diabetes and hypertension. Differentiating CKD from acute kidney injury (AKI) is crucial for managing these complex hepatorenal cases.

Area of Science:

  • Hepatology and Nephrology
  • Gastroenterology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) diagnosis is rising in liver cirrhosis patients.
  • Risk factors like diabetes, hypertension, and NAFLD contribute to CKD prevalence.
  • Newer CKD definitions aid differentiation from acute kidney injury (AKI).

Discussion:

  • CKD in cirrhosis can be structural or functional, stemming from kidney injury or circulatory imbalances.
  • Limited literature exists on combined cirrhosis-CKD, with focus often on AKI.
  • Challenges include GFR estimation, lack of biomarkers, and biopsy difficulties.

Key Insights:

  • AKI can progress to CKD in decompensated cirrhosis.
  • Combined hepatorenal dysfunction complicates fluid management and drug tolerance.
  • Clinical decision-making for transplantation (liver vs. liver-kidney) is challenging.

Outlook:

  • This review provides an overview of CKD in cirrhosis.
  • It highlights clinical consequences and diagnostic/treatment challenges.
  • Further research is needed to address knowledge gaps in combined hepatorenal disorders.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
90
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
55
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
340
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
185
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
245
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
273